Inventor

BUESKING ANDREW W

US23 patents

⚠️ This page may combine multiple inventors who share the name “BUESKING ANDREW W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BUESKING ANDREW W

INCYTE CORP

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

Bicyclic heterocycles as bet protein inhibitors

Bicyclic heterocycles as BET protein inhibitors

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

Tertiary alcohols as PI3K-γ inhibitors

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

Heterocyclic compounds as PI3K-γ inhibitors

Aza-heteroaryl compounds as PI3K-gamma inhibitors

Aza-heteroaryl compounds as PI3K-gamma inhibitors

Tertiary alcohols as PI3K-γ inhibitors

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

Tertiary alcohols as PI3K-γ inhibitors

Heterocyclic compounds as PI3K-y inhibitors

Aminopyrazine derivatives as PI3K-γ inhibitors

Tricyclic pyridone compounds as JAK2 V617F inhibitors

Tertiary alcohols as PI3K-γ inhibitors

Aminopyrazine derivatives as PI3K-γ inhibitors

Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

Heterocyclic compounds as PI3K-γ inhibitors

Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors

PRELUDE THERAPEUTICS INC

CDK inhibitors and their use as pharmaceuticals

CDK inhibitors and their use as pharmaceuticals